Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Surgery For Diabetes? CMS Will Look At The Evidence For Coverage

This article was originally published in The Gray Sheet

Executive Summary

In response to media attention focused on bariatric surgery's potential to send diabetes patients into remission, a skeptical CMS said last week that it would consider whether a new national Medicare coverage policy was needed
Advertisement

Related Content

CMS Proposes Coverage Of Surgery For Diabetes Only In Morbidly Obese
CMS Proposes Coverage Of Surgery For Diabetes Only In Morbidly Obese
CMS Fields Comments On Who Should Have Bariatric Surgery For Diabetes
CMS Fields Comments On Who Should Have Bariatric Surgery For Diabetes
J&J Stakes Claim For Growing Obesity And Diabetes Markets
J&J Stakes Claim For Growing Obesity And Diabetes Markets
Study Shows Gastric Banding Sends Diabetes Into Remission
Study Shows Gastric Banding Sends Diabetes Into Remission
Seniors Covered In New Medicare Policy For Bariatric Surgery
Advertisement
UsernamePublicRestriction

Register

MT026160

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel